Pro fi ling Analysis of Low Molecular Weight Heparins by Multiple Heart-Cutting Two Dimensional Chromatography with Quadruple Time-of-Flight Mass Spectrometry
Y. Ouyang,Yangyang Zeng,Yinxiu Rong,Yue Song,Lv Shi,Bo Chen,Xinlei Yang,N. Xu,R. Linhardt,Zhenqing Zhang
Abstract:Low molecular weight heparins (LMWHs) are polydisperse and microheterogenous mixtures of polysaccharides used as anticoagulant drugs. Profiling analysis is important for obtaining deeper insights into the structure of LMWHs. Previous oligosaccharide mapping methods are relatively low resolution and are unable to show an entire picture of the structural complexity of LMWHs. In the current study a profiling method was developed relying on multiple heartcutting, two-dimensional, ultrahigh performance liquid chromatography with quadruple time-of-flight mass spectrometry. This represents an efficient, automated, and robust approach for profiling LMWHs. Using size-exclusion chromatography and ion-pairing reversed-phase chromatography in a two-dimensional separation, LMW components of different sizes and LMW components of the same size but with different charges and polarities can be resolved, providing a more complete picture of a LMWH. Structural information on each component was then obtained with quadrupole time-of-flight mass spectrometry. More than 80 and 120 oligosaccharides were observed and unambiguously assigned from the LMWHs, nadroparin and enoxaparin, respectively. This method might be useful for quality control of LMWHs and as a powerful tool for heparin-related glycomics. H is one of the oldest drugs still used as a clinical anticoagulant, one of the few carbohydrate drugs, and one of the most complex drugs. Heparin is a mixture of sulfated linear polysaccharides with the most common repeating disaccharide unit corresponding to 2-O-sulfo-α-Liduronic acid (IdoA2S) 1 → 4-linked to 6-O-sulfo, N-sulfo-α-Dglucosamine (GlcNS6S), and variable disaccharide units being β-D-glucuronic acid (GlcA) or α-L-iduronic acid (IdoA) 1 → 4linked to 6-O-sulfo and/or 3-O-sulfo and/or N-sulfo (GlcNS) or N-acetylated (GlcNAc) α-D-glucosamine (Figure S1). A rare pentasaccharide sequence comprises the antithrombin III (AT)-binding site, GlcNAc/NS6S (1-4) GlcA (1-4) GlcNS3S,6S (1-4) IdoA2S (1-4) GlcNS6S, and is important for heparin’s anticoagulant activity. Like all other natural polysaccharides, heparin has dispersity of molecular weight (MW) and a microheterogenous structural composition with multiple sequences and the structures of its many different polysaccharide chains can depend on extraction sources and production processes. Different compositions, sequences, and structures of heparin chains can lead to different activities and, thus, quality control issues. The sulfo group location, number, and the placement of IdoA and GlcA are critically important for the specificity of heparin binding to different proteins. In 2007−2008, a rapid onset, acute side effect associated with heparin was reported, which was believed to be caused by a contaminant, oversulfated chondroitin sulfate (OSCS), leading to hypotension and resulting in nearly 100 deaths.8−10 This crisis initially went undetected as pharmacopeial methods were insufficient to monitor heparin structure or activity. For many years, analysts have been challenged to understand the complicated structures and sequences of heparin, limiting heparin’s quality control and its use in new apllications. In the 1990s, low molecular weight heparins (LMWHs) were introduced to reduce bleeding side effects in patients needing anticoagulation. Different strategies have been applied to Received: June 5, 2015 Accepted: July 29, 2015 Published: July 29, 2015 Article